APA

Bontkes H. J., Moreno M., Hangalapura B., Lindenberg J. J., de Groot J., Lougheed S., van der Vliet H. J. J., van den Eertwegh A. J. M., de Gruijl T. D., von Blomberg B. M. E. & Scheper R. J. (20100830). Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. : Clinical immunology (Orlando, Fla.).

Chicago

Bontkes Hetty J, Moreno María, Hangalapura Basav, Lindenberg Jelle J, de Groot Jan, Lougheed Sinéad, van der Vliet Hans J J, van den Eertwegh Alfons J M, de Gruijl Tanja D, von Blomberg B Mary E and Scheper Rik J. 20100830. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. : Clinical immunology (Orlando, Fla.).

Harvard

Bontkes H. J., Moreno M., Hangalapura B., Lindenberg J. J., de Groot J., Lougheed S., van der Vliet H. J. J., van den Eertwegh A. J. M., de Gruijl T. D., von Blomberg B. M. E. and Scheper R. J. (20100830). Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. : Clinical immunology (Orlando, Fla.).

MLA

Bontkes Hetty J, Moreno María, Hangalapura Basav, Lindenberg Jelle J, de Groot Jan, Lougheed Sinéad, van der Vliet Hans J J, van den Eertwegh Alfons J M, de Gruijl Tanja D, von Blomberg B Mary E and Scheper Rik J. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. : Clinical immunology (Orlando, Fla.). 20100830.